Latest filings (excl ownership)
15-12G
Securities registration termination
14 Feb 23
25-NSE
Exchange delisting
2 Feb 23
8-K
Biotech Acquisition Company Announces Liquidation
1 Feb 23
8-K
Submission of Matters to a Vote of Security Holders
25 Jan 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
11 Jan 23
DEF 14A
Definitive proxy
4 Jan 23
8-K
Entry into a Material Definitive Agreement
22 Dec 22
PRE 14A
Preliminary proxy
21 Dec 22
10-Q
2022 Q3
Quarterly report
21 Nov 22
NT 10-Q
Notice of late quarterly filing
14 Nov 22
8-K
Entry into a Material Definitive Agreement
11 Oct 22
10-Q
2022 Q2
Quarterly report
22 Aug 22
NT 10-Q
Notice of late quarterly filing
15 Aug 22
RW
Registration withdrawal request
17 Jun 22
8-K
Submission of Matters to a Vote of Security Holders
17 Jun 22
8-K
Biotech Acquisition Company and Blade Therapeutics Mutually Agree to Terminate Business
13 Jun 22
425
Business combination disclosure
2 Jun 22
8-K
Regulation FD Disclosure
2 Jun 22
425
Business combination disclosure
31 May 22
8-K
Regulation FD Disclosure
31 May 22
425
Business combination disclosure
24 May 22
424B3
Prospectus supplement
23 May 22
425
Business combination disclosure
23 May 22
8-K
Entry into a Material Definitive Agreement
23 May 22
425
Business combination disclosure
19 May 22
425
Business combination disclosure
18 May 22
425
Business combination disclosure
18 May 22
8-K
Regulation FD Disclosure
18 May 22
425
Business combination disclosure
17 May 22
425
Business combination disclosure
17 May 22
8-K
Blade Therapeutics Presents Data from Phase 1 and Preclinical Studies of Cudetaxestat at the American Thoracic Society 2022 International Conference
17 May 22
425
Business combination disclosure
16 May 22
8-K
Regulation FD Disclosure
16 May 22
10-Q
2022 Q1
Quarterly report
16 May 22
425
Business combination disclosure
13 May 22
EFFECT
Notice of effectiveness
10 May 22
425
Business combination disclosure
9 May 22
424B3
Prospectus supplement
9 May 22
425
Business combination disclosure
9 May 22
8-K
Entry into a Material Definitive Agreement
9 May 22
Latest ownership filings
SC 13G/A
Radcliffe Capital Management, L.P.
14 Feb 24
SC 13G/A
GOLDMAN SACHS GROUP INC
14 Feb 23
SC 13G
GLAZER CAPITAL, LLC
14 Feb 23
SC 13G/A
Beryl Capital Management LLC
13 Feb 23
SC 13G/A
ARISTEIA CAPITAL LLC
13 Feb 23
SC 13G
Radcliffe Capital Management, L.P.
27 Jan 23
SC 13G
Hudson Bay Capital Management LP
25 Jan 23
SC 13G
Beryl Capital Management LLC
16 May 22
SC 13G
Biotech Sponsor LLC
14 Feb 22
SC 13G/A
Atalaya Capital Management LP
14 Feb 22
SC 13G
ARISTEIA CAPITAL LLC
14 Feb 22
SC 13G
GOLDMAN SACHS GROUP INC
10 Feb 22
SC 13G/A
Atalaya Capital Management LP
14 Dec 21
SC 13G
Vellar Opportunities Fund Master, Ltd.
16 Feb 21
SC 13G
Atalaya Capital Management LP
5 Feb 21
3
Michael Schleifer
25 Jan 21
3
Bruno Montanari
25 Jan 21
3
Aaron Kim
25 Jan 21
3
Ivan Jarry
25 Jan 21
3
ALBERT F HUMMEL
25 Jan 21
3
Thomas Fratacci
25 Jan 21
3
Paul Bernard
25 Jan 21